Arturo Araya serves as Executive at BRAINSTORM CELL THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Arturo Araya has executed 5 insider transactions totaling $11.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 24, 2019 involved purchasing 3,000 shares valued at $11.7K.
Arturo Araya currently holds 8,608 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arturo Araya has been a net buyer of BCLI stock. They have purchased $11.7K and sold $0 worth of shares.
Arturo Araya's most recent insider trade was on Dec 24, 2019, when they purchased 3,000 shares at $3.90 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 26, 2018 | BCLI | $0 | Award | 1,249 | $N/A | Discretionary |
| Feb 26, 2018 | BCLI | $0 | Award | 4,152 | $N/A | Discretionary |
| Feb 26, 2017 | BCLI | $0 | Award | 3,012 | $N/A | Discretionary |